SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-014806
Filing Date
2021-04-28
Accepted
2021-04-28 17:21:03
Documents
14
Period of Report
2021-04-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nt10022735x17_8k.htm   iXBRL 8-K 30886
2 EXHIBIT 99.1 nt10022735x17_ex99-1.htm EX-99.1 11341
6 nt10022735x17_ex99-1image01.jpg GRAPHIC 2875
  Complete submission text file 0001140361-21-014806.txt   185654

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA advm-20210428.xsd EX-101.SCH 3920
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20210428_lab.xml EX-101.LAB 22544
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20210428_pre.xml EX-101.PRE 16040
7 EXTRACTED XBRL INSTANCE DOCUMENT nt10022735x17_8k_htm.xml XML 4044
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 21865610
SIC: 2836 Biological Products, (No Diagnostic Substances)